R. Taylor Ripley MD
Adult General Thoracic Surgery, Minimally Invasive Thoracic Surgery, Thoracic Surgical Oncology
Meyer-DeBakey Chair in Investigative Surgery / Professor / Thoracic Surgeon, Baylor College of Medicine / Director, Mesothelioma Treatment Center / Director, Thoracic Surgical Research / Director, Clinical Trials for Department of Surgery / Editor, Seminars in Thoracic and Cardiovascular Surgery / Vice President, Board of Directors; Mesothelioma Applied Research Foundation
Join to View Full Profile
7200 Cambridge StSuite 6AHouston, TX 77030
Phone+1 713-798-6376
Dr. Ripley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- My primary clinical focus is the on treatment of patients in the Mesothelioma Treatment Center at Baylor College of Medicine. Additionally, I treat patients with all thoracic cancers including lung cancer, esophageal cancer, thymic cancers, and metastatic disease. I utilize robotic surgery to minimize the size of surgical incisions whenever feasible. Also, I focus on chest wall surgery including Slipping Rib Syndrome. Our research laboratory studies tumor metabolism to increase tumor susceptible to therapy.
Vice President, Board of Directors of Meso Foundation. Thoracic Editor, Seminars in Thoracic and Cardiovascular Surgery. Steering Committee, International Association for the Study of Lung Cancer, Mesothelioma Project.
Steering Committee, National Mesothelioma Virtual Database. Member American Association of Thoracic Surgeons.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Thoracic Surgery - Independent, 2012 - 2014
University of ColoradoResidency, Surgery, 2004 - 2012
National Cancer Institute2007 - 2010
Vanderbilt University School of MedicineClass of 2004
Boston CollegeBS, Biochemistry, Summa Cum Laude, 2000
Certifications & Licensure
TX State Medical License 2018 - 2028
MD State Medical License 2016 - 2021
NY State Medical License 2012 - 2017
CO State Medical License 2007 - 2013
PA State Medical License 2013 - 2013
DC State Medical License 2009 - 2010
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Phi Beta Kappa Boston College, 1999
- Dean’s Scholar Boston College, 1999
- Dan May Scholarship: Basic science research grant Vanderbilt University School of Medicine, 2001
Publications & Presentations
PubMed
- Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesions.Yupei Lin, Venugopalareddy Mekala, Jianrong Li, Xiang Wang, Muhammad Aminu
International Journal of Cancer. 2025-12-16 - A Response to the Letter to the Editor: Refining Risk and Redefining Stage: Hidden Implications of BAP1-Mutant Mesothelioma Shiuan-Chih Chen, MD, PhD; Yuan-Ti Lee, MD,...Michele Carbone, Michael Minaai, Muaiad Kittaneh, Thomas Krausz, Markku M Miettinen
Journal of Thoracic Oncology. 2025-12-01 - 11 citationsClinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations.Michele Carbone, Michael Minaai, Muaiad Kittaneh, Thomas Krausz, Markku M Miettinen
Journal of Thoracic Oncology. 2025-11-01
Books/Book Chapters
Abstracts/Posters
- Incidence of Second Primary Lung Cancers in Smokers Versus Non-smokers after Curative Resection of Stage I Lung Adenocarcinoma. (Oral Presentation)R. Taylor Ripley, MD, Robert R. McMillan, MD MPH, Camelia S. Sima, MD MS, Saad M. Hasan, BA, Feiran Lou, MD, Valerie Rusch, MD, Nabil P. Rizk, MD, James Huang, MD, 50th Annual Meeting of the Society of Thoracic Surgeons, Orlando, FL, 1/1/2014
- A Stem Cell Ligand Induced by Cigarette Smoke Enhances the Malignant Phenotype of Lung Cancer Cells.Robert T. Ripley, Clinton D. Kemp, Aarti Mathur, Julie A. Hong, Mary Zhang, Mahadev Rao, David S. Schrump, 92nd Annual Meeting of the American Association for Thoracic Surgery, Oral Presentation for Lillehei Forum for Resident Research Competition, San Francisco, CA, 4/1/2012
- Wnt-5A Modulates Global Gene Expression Profiles and Enhances the Malignant Phenotype of Lung Cancer Cells. (Poster Presentation)R. Taylor Ripley, Mahadev Rao, Julie A. Hong, Clinton D. Kemp, Aarti Mathur, Mary Zhang, David S. Schrump, The American Association for Cancer Research 101st Annual Meeting, Washington, DC, 4/1/2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
